
Boston Scientific Corporation (NYSE:BSX)’s REPRISE II Clinical Data Demonstrates Effectiveness And Safety Of Lotus™ Valve System
Boston, MA 09/17/2014 (wallstreetpr) – The clinical trial of Lotus™ Valve System of Boston Scientific Corporation (NYSE:BSX) is enduringly proving its performance in terms of












